SD-983

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSD-983
Drug Alias NameSG-545SD-863SD-983
ClassificationSmall molecules
Mechanisms of ActionAngiogenesis inhibitorsIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsAngiogenesis disorderColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Pharma Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Pharma CompanyBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A